Spectral-domain Optical Coherence Tomography of the Eye

November 22, 2015 updated by: Augenabteilung Allgemeines Krankenhaus Linz

A Prospective, Comparative, Observational Study on Spectral-domain Optical Coherence Tomography of the Eye

An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new clinical applications has recently been published in the peer-reviewed literature. However, the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity, biometric accuracy and reliability of the SD-OCT machines. This prospective, comparative, observational study aims to evaluate the imaging quality and diagnostic performance of two commercially available SD-OCT machines for both the anterior and posterior segment of the eye.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oberösterreich
      • Linz, Oberösterreich, Austria, 4021
        • Recruiting
        • AKH Linz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

200 eyes of 100 patients will be included.

Description

Inclusion Criteria:

  • Age 21 and older
  • Normal eyes or
  • Eyes with corneal disease:

Subjects that have any of the following conditions

  1. Corneal dystrophy or degeneration
  2. Corneal scarring
  3. Corneal ulcer
  4. Corneal injury
  5. Keratoconus
  6. Patients who had undergone corneal surgery
  7. Patients with other corneal disease or - Eyes with retinal disease:

Subjects that have any of the following conditions:

  1. Diabetic macular edema
  2. Cystoid macular edema
  3. Age related macular degeneration
  4. Retinal vascular disorders (e.g. retinal artery occlusion)
  5. Epiretinal membrane
  6. Choroidal nevus
  7. Macular hole
  8. Patients who had undergone retinal surgery
  9. Patients with other retinal disease or

    • Eyes with glaucoma
    • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant.

AND

- Written informed consent prior to recruitment

Exclusion Criteria:

Any of the following will exclude a subject from the study:

  • Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus)
  • Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment into the trial)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Normal subjects
Patient with healthy, normal eyes
Eyes with corneal disease

Subjects that have any of the following conditions

  • Corneal dystrophy or degeneration
  • Corneal scarring
  • Corneal ulcer
  • Corneal injury
  • Keratoconus
  • Patients who had undergone corneal surgery
  • Patients with other corneal disease
Eyes with retinal disease

Subjects that have any of the following conditions:

  • Diabetic macular edema
  • Cystoid macular edema
  • Age related macular degeneration
  • Retinal vascular disorders (e.g. retinal artery occlusion)
  • Epiretinal membrane
  • Choroidal nevus
  • Macular hole
  • Patients who had undergone retinal surgery
  • Patients with other retinal disease
Eyes with glaucoma
Eyes diagnosed with glaucoma of any type and any stage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity as the proportion of anatomical structures that are detectable with the two instruments
Time Frame: 6 months
Anatomical structures include e.g. sublayers of the cornea, sublayers of the retina, retinal vessels etc.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Corneal sublayer thickness (µm) and retinal sublayer thickness (µm) obtained with the two study instruments
Time Frame: 6 months
Comparability is analyzed between various biometric values obtained with the two instruments and typical indices of comparability are produced (e.g. intraclass correlation coefficient)
6 months
Corneal sublayer thickness and retinal sublayer thickness obtained with the two study instruments
Time Frame: 6 months
Repeatability for various biometric values obtained with the two instruments is analyzed and typical indices of repeatability are produced (e.g. coefficient of variation)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthias Bolz, MD, AKh Linz, Augenabteilung

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Anticipated)

December 1, 2015

Study Completion (Anticipated)

December 1, 2015

Study Registration Dates

First Submitted

October 12, 2015

First Submitted That Met QC Criteria

November 22, 2015

First Posted (Estimate)

November 25, 2015

Study Record Updates

Last Update Posted (Estimate)

November 25, 2015

Last Update Submitted That Met QC Criteria

November 22, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • OCTComparisonstudy1.1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Subscribe